Companies: 10,795·Total market cap: $144.5T
Chinook Therapeutics, Inc.

Chinook Therapeutics, Inc.

KDNYNASDAQHealthcare
$40.39
+$0.09(+0.22%)
Market Cap$2.7B
P/E Ratio—
52W High$40.51
52W Low$18.34
Overview

Chinook Therapeutics, Inc. (KDNY) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001435049 · KDNY · NASDAQ · as of Jun 10, 2026

Filing snapshot

765
Total Filings
SC 13D/A
Latest Form
2023-11-22
Most Recent
2020
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001435049 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2023-02-27
Fiscal Year End
Feb 27, 2023
Accession No.
0001564590-23-002589
Primary Document
kdny-10k_20221231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001435049 · Accession 0001564590-23-002589

Latest Key Filings

10-QQuarterly Report
10-Q
2023-08-07
View 10-Q on SEC
8-KCurrent Report
8-K
2023-08-11Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SC 13D/ASC 13D/A
SC 13D/A
2023-11-22
View
15-12G15-12G
15-12G
2023-08-21
View
EFFECTEFFECT
EFFECT
2023-08-16
View
SC 13DActivist Ownership Report
Activist Ownership Report
2023-08-11
View
S-8 POSS-8 POS
S-8 POS
2023-08-11
View
S-8 POSS-8 POS
S-8 POS
2023-08-11
View
S-8 POSS-8 POS
S-8 POS
2023-08-11
View
S-8 POSS-8 POS
S-8 POS
2023-08-11
View
S-8 POSS-8 POS
S-8 POS
2023-08-11
View
S-8 POSS-8 POS
S-8 POS
2023-08-11
View
S-8 POSS-8 POS
S-8 POS
2023-08-11
View
S-8 POSS-8 POS
S-8 POS
2023-08-11
View
S-8 POSS-8 POS
S-8 POS
2023-08-11
View
S-8 POSS-8 POS
S-8 POS
2023-08-11
View
S-8 POSS-8 POS
S-8 POS
2023-08-11
View
Showing 1–15 of 379 filingsForm 4 / 144 hidden· 765 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001435049  |  Exchange: NASDAQ · Healthcare

Chinook Therapeutics, Inc. (NASDAQ: KDNY) has submitted 765 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001435049, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Chinook Therapeutics, Inc.'s most comprehensive regulatory disclosure. The most recent Chinook Therapeutics, Inc. 10-K was filed on 2023-02-27 for fiscal year ending 2023. Historical KDNY 10-K annual reports are available from 2008 through 2023.

Investors researching Chinook Therapeutics, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Healthcare
MOR SEC Filings →SWTX SEC Filings →MORF SEC Filings →MYOV SEC Filings →PRVB SEC Filings →LBPH SEC Filings →DICE SEC Filings →BLU SEC Filings →
→ KDNY Financials→ KDNY Earnings→ KDNY Insider Trades

Frequently Asked Questions

KDNY SEC Filings · 8 questions

Chinook Therapeutics, Inc. (KDNY) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 765 filings and access original documents at no cost. Chinook Therapeutics, Inc.'s CIK is 0001435049.

KDNY SEC filingsChinook Therapeutics, Inc. SEC documentsfind KDNY 10-K